Title: Targeted metabolomics reveals plasma short-chain fatty acids are associated with
metabolic dysfunction-associated steatotic liver disease
Version: 3 Date: 31 Dec 2023
Reviewer's report:
The authors have addressed all concerns about the length of fasting, medication, prior diet, and
probiotic influences on the results.  I have no additional comments for the authors to address.
Title: Targeted metabolomics reveals plasma short-chain fatty acids are associated with
metabolic dysfunction-associated steatotic liver disease
Version: 3 Date: 31 Dec 2023
Reviewer's report:
The authors have addressed all concerns about the length of fasting, medication, prior diet, and
probiotic influences on the results.  I have no additional comments for the authors to address.
Please review this paper.
user
Title: Targeted metabolomics reveals plasma short-chain fatty acids are associated with
metabolic dysfunction-associated steatotic liver disease
Version: 3 Date: 31 Dec 2023
Reviewer's report:
The authors have addressed all concerns about the length of fasting, medication, prior diet, and
probiotic influences on the results.  I have no additional comments for the authors to address.
assistant